Third keystone symposium on cellular immunology and the immunotherapy of cancer antigen processing and presentation chimpanzee dendritic cells derived in vitro from blood monocytes and pulsed with antigen elicit specific immune responses in vivo

Journal of Immunotherapy

Volumn 21, Issue 2, 1998, Pages 142-148

  Barratt Boyes, Simon M ^a   Kao, Henry ^a   Finn, Olivera J ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Cancer immunotherapy; Chimpanzee; Dendritic cells; In vivo animal models; Vaccines

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; CHIMPANZEE; CONFERENCE PAPER; DENDRITIC CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; MALIGNANT NEOPLASTIC DISEASE; MONOCYTE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; ANTIGENS; ANTIGENS, NEOPLASM; DENDRITIC CELLS; EPITOPES; FEMALE; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; INJECTIONS, INTRAVENOUS; LEUKOCYTES, MONONUCLEAR; LYMPH NODES; LYMPHOCYTE ACTIVATION; MALE; OVALBUMIN; PAN TROGLODYTES; T-LYMPHOCYTES; VACCINATION;

EID: 0031913543     PISSN: 15249557     EISSN: 15374513     Source Type: Journal    
DOI: 10.1097/00002371-199803000-00008     Document Type: Article

References (35)

1. Henderson RA, Finn OJ. Human tumor antigens are ready to fly. Adv Immunol 1996;62:217-56.
2. Chen L, Linsley PS, Hellström KE. Costimulation of T cells for tumor immunity. Immunol Today 1993;14:483-6.
3. Grabbe S, Beissert S, Schwarz T, Granstein RD. Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy? Immunol Today 1995;16:117-21.
4. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-96.
5. Macatonia SE, Knight SC, Edwards AJ, Griffiths S, Fryer P. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. J Exp Med 1987;166:1654-67.
6. Inaba K, Witmer-Pack M, Inaba M, et al. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med 1994;180:1849-60.
7. Santiago-Schwarz F, Belilos E, Diamond B, Carsons SE. TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J Leukocyte Biol 1992;52:274-81.
8. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 1992;360:258-61.
9. + progenitors in human bone marrow. J Immunol 1992;149:2681-8.
10. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med 1994;179:1109-18.
11. Romani N, Gruner S, Brang D, et al. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994;180:83-93.
12. Mayordomo JI, Zorina T, Storkus WJ, et al. Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity. Nature Med 1995;1:1297-302.
13. Mayordomo JI, Loftus DJ, Sakamoto H, et al. Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines. J Exp Med 1996;183:1357-65.
14. Porgador A, Snyder D, Gilboa E. Induction of antitumor immunity using bone marrow-generated dendritic cells. J Immunol 1996;156:2918-26.
15. Zitvogel L, Mayordomo JI, Tjandrawan T, et al. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J Exp Med 1996;183:87-97.
16. Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo LD. Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J Exp Med 1996;183:283-7.
17. Barratt-Boyes SM, Henderson RA, Finn OJ. Chimpanzee dendritic cells with potent immunostimulatory function can be propagated from peripheral blood. Immunology 1996;87:528-34.
18. Finn OJ, Jerome KR, Henderson RA, et al. MUC-1 epithelial tumor mucin-based immunity and cancer vaccines. Immunol Rev 1995;145:61-89.
19. Fontenot JD, Finn OJ, Dales N, Andrews PC, Montelaro RC. Synthesis of large multideterminant peptide immunogens using a polyproline α-turn helix motif. Peptide Res 1993;6:1-7.
20. Flamand V, Somasse T, Thielemans K, et al. Murine dendritic cells pulsed in vitro with tumor antigen induce resistance in vivo. Eur J Immunol 1994;24:605-10.
21. Hsu FJ, Benike C, Fagnoni F, et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med 1996;2:52-8.
22. Kotera Y, Fontenot JD, Pecher G, Metzgar RS, Finn OJ. Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients. Cancer Res 1994;54:2856-60.
23. + CTLs from naive precursors. J Immunol 1994;153:996-1003.
24. + T cell lines from naive precursors. Eur J Immunol 1995;95:1206-11.
25. Burchell J, Taylor-Papadimitriou J, Boshell M, Gendler S, Duhig T. A short sequence, within the amino acid tandem repeat of a cancer-associated mucin, contains immunodominant epitopes. Int J Cancer 1989;44:691-6.
26. Jerome KR, Bamd DL, Bendt KM, et al. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res 1991;51:2908-16.
27. Barnd DL, Lan MS, Metzgar RS, Finn OJ. Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc Natl Acad Sci USA 1989;86:7159-63.
28. Agrawal B, Reddish MA, Krantz MJ, Longenecker BM. Does pregnancy immunize against breast cancer? Cancer Res 1995;55:2257-61.
29. Jerome KR, Kirk AD, Pecher G, Ferguson WW, Finn OJ. A sur vivor of breast cancer with immunity to MUC-1 mucin, and lactational mastitis. Cancer Immunol Immunother 1997;43:355-60.
30. Pecher G, Finn OJ. Induction of cellular immunity in chimpanzees to human tumor-associated antigen mucin by vaccination with MUC-1 cDNA-transfected Epstein-Barr virus-immortalized autologous B cells. Proc Natl Acad Sci USA 1996;93:1699-704.
31. Inaba K, Inaba M, Naito M, Steinman RM. Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J Exp Med 1993;178:479-88.
32. Porgador A, Gilboa E. Bone marrow-generated dendritic cells pulsed with a Class-I restricted peptide are potent inducers of cytotoxic T lymphocytes. J Exp Med 1995;182:255-60.
33. Barratt-Boyes SM, Watkins SC, Finn OJ. In vivo migration of dendritic cells differentiated in vitro: a chimpanzee model. J Immunol 1997;158:4543-7.
34. Condon C, Watkins SC, Celluzzi CM, Thompson K, Falo LD Jr. DNA-based immunization by in vivo transfection of dendritic cells. Nature Med 1996;2:1122-8.
35. Henderson RA, Nimgoankar MT, Watkins SC, Robbins PD, Ball ED, Finn OJ. Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1). Cancer Res 1996;56:3763-70.